Prophylaxis for opportunistic infections in patients with HIV infection

JE Gallant, RD Moore, RE Chaisson - Annals of internal medicine, 1994 - acpjournals.org
Objective: To review the efficacy of chemoprophylaxis for opportunistic infections in persons
infected with human immunodeficiency virus (HIV). Data Sources: English-language articles …

Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review

YS Huang, JJ Yang, NY Lee, GJ Chen… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: Pneumocystis pneumonia is a potentially life-threatening pulmonary infection
that occurs in immunocompromised individuals and HIV-infected patients with a low CD4 …

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

HC Bucher, GH Guyatt, LE Griffith, SD Walter - Journal of clinical …, 1997 - Elsevier
When little or no data directly comparing two treatments are available, investigators often
rely on indirect comparisons from studies testing the treatments against a control or placebo …

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection

SA Bozzette, DM Finkelstein, SA Spector… - … England Journal of …, 1995 - Mass Medical Soc
Background We evaluated the effectiveness of three treatment strategies for the prevention
of a first episode of Pneumocystis carinii pneumonia in patients infected with the human …

A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens

JPA Ioannidis, JC Cappelleri, PR Skolnik… - Archives of Internal …, 1996 - jamanetwork.com
Background: Finding the optimal strategy forPneumocystis cariniiprophylaxis in patients with
human immunodeficiency virus infection can be problematic. Several prophylactic regimens …

[HTML][HTML] The function of HLA-B* 13: 01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions

WT Chen, CW Wang, CW Lu, CB Chen, HE Lee… - Journal of Investigative …, 2018 - Elsevier
Dapsone-induced hypersensitivity reactions may cause severe cutaneous adverse
reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS). It has …

Prevention of Infection Due to Pneumocystis carinii

JA Fishman - Antimicrobial agents and chemotherapy, 1998 - Am Soc Microbiol
Pneumocystis carinii remains an important pathogen for the broad spectrum of
immunocompromised individuals, despite significant advances in antimicrobial therapy. The …

Use of Dapsone in the Prevention and Treatment of Pneumocystis carinii Pneumonia: A Review

WT Hughes - Clinical infectious diseases, 1998 - academic.oup.com
Dapsone, with or without trimethoprim or pyrimethamine, has strong anti-Pneumocystis
carinii activity, as demonstrated by in vitro methods, animal studies, and clinical trials. The …

Intermittent Trimethoprim-Sulfamethoxazole Compared with Dapsone-Pyrimethamine for the Simultaneous Primary Prophylaxis of Pneumocystis Pneumonia and …

D Podzamczer, A Salazar, J Jimenez… - Annals of internal …, 1995 - acpjournals.org
Objective: To evaluate the efficacy and safety of two oral, intermittent drug regimens for the
simultaneous primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in …

The promises and challenges of pre‐exposure prophylaxis as part of the emerging paradigm of combination HIV prevention

CF Cáceres, F Koechlin, P Goicochea… - Journal of the …, 2015 - Wiley Online Library
Introduction Towards the end of the twentieth century, significant success was achieved in
reducing incidence in several global HIV epidemics through ongoing prevention strategies …